In conclusion, the serum exosomal DIO3OS-hsa-miR-27a-3p-HOXA10 competitive endogenous mechanism signaling axis affects ovarian cancer development and disease survival by targeting dysregulated transcriptional pathways in cancer. Here, HOXA10 is linked to ovarian carcinoma.